Skip to main content

Table 2 Baseline sociodemographic and clinical characteristics of 20 consenting participants

From: Pain management in inflammatory bowel disease: feasibility of an online therapist-supported CBT-based self-management intervention

Characteristic

Recruited participants (n = 20)

Sociodemographic

 Age, mean (SD), yr

38.40 (9.87)

 Female

16 (80)

 English/Welsh/Scottish/N Irish/British

19 (95)

 University degree or higher

13 (65)

Employment status

 Employed full-time

10 (50)

 Employed part-time

2

 Full- or part-time education

2

 Full-time domestic

1 (5)

 Retired

1 (5)

 Unemployed

4 (20)

Relationship status

 Married/civil partnership

9 (45)

 Living with partner

5 (25)

 Divorced

1 (5)

 Single

5 (25)

Clinical

 Diagnosis (CD/UC/IBD-U)

16 (80)/4 (20)/0 (0)

 Disease duration mean (SD) (yrs)

13.20 (10.46)

 Faecal calprotectin mean (SD) ug/g

175.69 (205.69)

IBD medication

 5-ASA

6 (30)

 Thiopurines

4 (20)

 Anti-TNF (infliximab/adalimumab)

3 (15)/4 (20)

 Vedolizumab

1 (5)

 Steroids (methotrexate/budesonide/prednisolone)

3 (15) /3 (15) /2 (10)

 Ustekinumab

5 (25)

 None

2 (10)

 Previous surgery

12 (60)

Surgeries

 Resection

5 (25)

 Colectomy

3 (15)

 Stoma

2 (10)

Smoking history

 Current smoker

3 (15)

 Previous smoker

5 (25)

 Non-smoker

12 (60)

Pain locations

 Abdomen

18 (85)

 Joints

14 (70)

 Back

13 (65)

 Head

8 (40)

Pain medications

 Paracetamol

10 (50)

 Co-codamol

4 (20)

 Opioids

10 (50)

 Pregabalin

1 (5)

 NSAIDs

3 (15)

 Tricyclic antidepressants

3 (15)

 Antispasmodics

1 (5)

 Omeprazole

1 (5)

 Benzodiazepine

1 (5)

 Other (anti-diarrhoeal, anti-bile acid)

0 (0)

  1. NB count displayed as % unless otherwise specified